Bo Ma
Impact in
-
- Natural Compounds in Disease Treatment
- Cancer Research top 5%
Papers in
-
- Metabolomics and Mass Spectrometry Studies 8
- Bioactive Natural Diterpenoids Research 6
- Bone Metabolism and Diseases 6
- Natural product bioactivities and synthesis 5
-
- Natural Compounds in Disease Treatment 7
- Co-authors
- Qi Zhang (40 shared papers)Razelle Kurzrock (3 shared papers)Gerald S. Falchook (3 shared papers)C. Martin Curtis (4 shared papers)Jeffrey R. Infante (3 shared papers)Danièle Ouellet (2 shared papers)Michael Millward (2 shared papers)Richard Kefford (2 shared papers)
- Journals
- Andrologia (5 papers)Acta Pharmacologica Sinica (5 papers)Chemico-Biological Interactions (4 papers)Phytomedicine (4 papers)Journal of Chromatography B (4 papers)
- Partner nations
- ChinaUnited StatesNew Zealand
In The Last Decade
Bo Ma
115 papers receiving 3.5k citations
Bo Ma's Hit Papers
Peers
Comparison fields: 5 of 142
- Complementary and alternative medicine 233
- Cancer Research 336
- Oncology 604
- Molecular Biology 1.6k
- Reproductive Medicine 180
Countries citing papers authored by Bo Ma
This map shows the geographic impact of Bo Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Ma more than expected).
Fields of papers citing papers by Bo Ma
This network shows the impact of papers produced by Bo Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Ma. The network helps show where Bo Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Bo Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 120 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial Hit paper breakdown → | 2012 | 721 |
| 2 | 2014 | 171 | |
| 3 | 2013 | 95 | |
| 4 | 2021 | 89 | |
| 5 | 2018 | 88 | |
| 6 | 2017 | 88 | |
| 7 | 2018 | 85 | |
| 8 | 2020 | 82 | |
| 9 | 2006 | 78 | |
| 10 | 2015 | 75 | |
| 11 | 2020 | 71 | |
| 12 | 2009 | 70 | |
| 13 | 2019 | 67 | |
| 14 | 2019 | 65 | |
| 15 | 2015 | 59 | |
| 16 | 2014 | 51 | |
| 17 | 2020 | 51 | |
| 18 | 2016 | 50 | |
| 19 | 2019 | 50 | |
| 20 | 2012 | 47 |
About Bo Ma
Bo Ma is a scholar working on Molecular Biology, Complementary and alternative medicine, Biomedical Engineering, Cancer Research and Oncology, having authored 120 papers that have together received 3.6k indexed citations. Recurring topics across this work include Metabolomics and Mass Spectrometry Studies (8 papers), Sperm and Testicular Function (8 papers), Nanoplatforms for cancer theranostics (8 papers), Natural Compounds in Disease Treatment (7 papers), Bioactive Natural Diterpenoids Research (6 papers), Bone Metabolism and Diseases (6 papers), Natural product bioactivities and synthesis (5 papers) and Plant-based Medicinal Research (5 papers). The work is most often cited by research in Complementary and alternative medicine (233 citations), Cancer Research (336 citations), Oncology (604 citations), Molecular Biology (1.6k citations) and Reproductive Medicine (180 citations). Bo Ma has collaborated with scholars based in China, United States and New Zealand. Frequent co-authors include Qi Zhang, Razelle Kurzrock, Gerald S. Falchook, C. Martin Curtis, Jeffrey R. Infante, Danièle Ouellet, Michael Millward, Richard Kefford, Omid Hamid and Georgina V. Long. Their work appears in journals such as Andrologia, Acta Pharmacologica Sinica, Chemico-Biological Interactions, Phytomedicine and Journal of Chromatography B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.